Absence of somatic mutations in natriuretic peptide receptor type A gene in human aldosterone-secreting adenomas

Journal of Molecular Endocrinology

Volumn 31, Issue 2, 2003, Pages 317-326

  Sarzani, R ^b,c   Salvi, F ^b   Pietrucci, F ^b   Buglia, L ^b   Candelaresi, C ^b   Balducci, B ^b   Francioni, M ^b   Fazioli, F ^b   Letizia, C ^a   D'Erasmo, E ^a   Dessi Fulgheri P ^b   Rappelli, A ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c Clinica di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BETA ACTIN; BRAIN NATRIURETIC PEPTIDE; COMPLEMENTARY DNA; GENOMIC DNA; HORMONE RECEPTOR; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR; REGULATOR PROTEIN; RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADENOMA; ADULT; ALDOSTERONE RELEASE; ARTICLE; BINDING SITE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA PURIFICATION; DNA SEQUENCE; DNA SYNTHESIS; EXON; FEMALE; GENE AMPLIFICATION; HOUSEKEEPING GENE; HUMAN; MALE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA EXTRACTION; RNA STABILITY; SAMPLE; SOMATIC MUTATION;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ALDOSTERONE; BLOTTING, NORTHERN; FEMALE; GUANYLATE CYCLASE; HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 10744222835     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0310317     Document Type: Article

References (26)

1. Anderson JV, Struthers AD, Payne NN, Slater JD & Bloom SR 1986 Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clinical Science 70 507-512.
2. sα protein in growth hormone-secreting tumors. Journal of Clinical Endocrinology and Metabolism 83 4386-4390.
3. Davies E, Bonnardeaux A, Plouin PF, Corvol P & Clauser E 1997 Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. Journal of Clinical Endocrinology and Metabolism 82 611-615.
4. Higuchi K, Nawata H, Kato K, Ibayashi H & Matsuo H 1986a Lack of inhibitory effect of alpha-human atrial natriuretic polypeptide on aldosteronogenesis in aldosterone-producing adenoma. Journal of Clinical Endocrinology and Metabolism 63 192-196.
5. Higuchi K, Nawata H, Kato K, Ibayashi H & Matsuo H 1986b Alpha-human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells. Journal of Clinical Endocrinology and Metabolism 62 941-944.
6. Holmes SJ, Espiner EA, Richards AM, Yandle TG & Frampton C 1993 Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. Journal of Clinical Endocrinology and Metabolism 76 91-96.
7. Knowles JW, Erickson LM, Guy VK, Sigel CS, Wilder JC & Maeda N 2003 Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Human Genetics 112 62-70.
8. sα mutation. Endocrine Journal 47 461-466.
9. Latronico AC, Reincke M, Mendonca BB, Arai K, Mora P, Allolio B, Wajchenberg BL, Chrousos GP & Tsigos C 1995 No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. Journal of Clinical Endocrinology and Metabolism 80 875-877.
10. Maack T, Nikonova LN, Friedman O & Cohen D 1996 Functional properties and dynamics of natriuretic peptide receptors. Proceedings of the Society for Experimental Biology and Medicine 213 109-116.
11. Misquitta CM, Iyer VR, Werstiuk ES & Grover AK 2001 The role of 3′-untranslated region (3′-UTR) mediated mRNA stability in cardiovascular pathophysiology. Molecular and Cellular Biochemistry 224 53-67.
12. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M & Imura H 1990 Human brain natriuretic peptide, a novel cardiac hormone. Lancet 335 801-802.
13. Opocher G, Rocco S, Carpene G, Vettoretti A, Cimolato M & Mantero F 1992 Usefulness of atrial natriuretic peptide assay in primary aldosteronism. American Journal of Hypertension 5 811-816.
14. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J & Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365 649-651.
15. sα genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 82 2695-2701.
16. Pitzalis MV, Sarzani R, Dessi-Fulgheri P, Iacoviello M, Forleo C, Lucarelli K, Pietrucci F, Salvi F, Sorrentino S, Romito R, Guida P, Rappelli A & Rizzon P 2003 Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. Journal of Hypertension 21 1491-1496.
17. Rocco S, Opocher G, D'Agostino D, Leone L & Mantero F 1989 Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies. Journal of Endocrinological Investigation 12 13-17.
18. Rocco S, Opocher G, Carpene G & Mantero F 1990 Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects. American Journal of Hypertension 3 668-673.
19. Sachse R, Shao XJ, Rico A, Finckh U, Rolfs A, Reincke M & Hensen J 1997 Absence of angiotensin II type 1 receptor gene mutations in human adrenal tumors. European Journal of Endocrinology 137 262-266.
20. Sarzani R, Fallo F, Dessi-Fulgheri P, Pistorello M, Lanari A, Paci VM, Mantero F & Rappelli A 1992 Local renin-angiotensin system in human adrenals and aldosteronomas. Hypertension 19 702-707.
21. Sarzani R, Opocher G. Dessi-Fulgheri P, Paci V, Cola G, Rocco S, Vianello B, Mantero F & Rappelli A 1995 Expression of type 1 angiotensin II receptors in human aldosteronomas. Endocrine Research 21 189-195.
22. Sarzani R, Opocher G, Paci MV, Belloni AS, Mantero F, Dessi-Fulgheri P & Rappelli A 1999 Natriuretic peptides receptors in human aldosterone-secreting adenomas. Joumal of Endocrinological Investigation 22 514-518.
23. Takahashi Y, Nakayama T, Soma M, Izumi Y & Kanmatsuse K 1998 Organization of the human natriuretic peptide receptor A gene. Biochemical and Biophysical Research Communication 246 736-739.
24. Yamaji T, Ishibashi M, Sekihara H, Takaku F, Nakaoka H & Fujii J 1986 Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. Journal of Clinical Endocrinology and Metabolism 63 815-818.
25. Zenkert S, Schubert B, Fassnacht NI, Beuschlein F, Allolio B & Reincke M 2000 Steroidogenic acute regulaton protein mRNA expression in adrenal tumours. European Journal of Endocrinology 142 294-299.
26. Zwermann O, Beuschlein F, Mora P, Weber G, Allolio, B & Reincke M 2000 Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. European Journal of Endocrinology 142 689-695.